title: Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni).
abstract: noni, the juice of the fruit from the Morinda citrifolia plant, has been used for centuries as a medicinal agent. We tested the effects of noni juice in a three-dimensional fibrin clot matrix model using human placental vein and human breast tumor explants as sources for angiogenic vessel development. Noni in concentrations of 5% (vol/vol) or greater was highly effective in inhibiting the initiation of new vessel sprouts from placental vein explants, compared with initiation in control explants in media supplemented with an equivalent amount of saline. These concentrations of noni were also effective in reducing the growth rate and proliferation of newly developing capillary sprouts. When used at a concentration of 10% in growth media, noni was able to induce vessel degeneration and apoptosis in wells with established capillary networks within a few days of its application. We also found that 10% noni juice in media was an effective inhibitor of capillary initiation in explants from human breast tumors. In tumor explants which did show capillary sprouting, the vessels rapidly degenerated (2-3 days) in those exposed to media supplemented with 10% noni.
authors.affiliation: Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. chorni@lsuhsc.edu
authors.forename: Conrad A
authors.initials: CA
authors.lastname: Hornick
authors.forename: Amy
authors.initials: A
authors.lastname: Myers
authors.forename: Halina
authors.initials: H
authors.lastname: Sadowska-Krowicka
authors.forename: Catherine T
authors.initials: CT
authors.lastname: Anthony
authors.forename: Eugene A
authors.initials: EA
authors.lastname: Woltering
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000098:blood supply / Q000188:drug therapy; D005260:Female; D006801:Humans; D032066:Morinda; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D010920:Placenta / Q000098:blood supply / Q000187:drug effects; D028321:Plant Preparations / Q000494:pharmacology*; D011247:Pregnancy; D013997:Time Factors
chemical_list: D020533:Angiogenesis Inhibitors; D028321:Plant Preparations